国际肿瘤学杂志››2017,Vol. 44››Issue (4): 284-286.doi:10.3760/cma.j.issn.1673-422X.2017.04.011
王佳峰,葛明华
出版日期:2017-04-08发布日期:2017-05-09通讯作者:葛明华 E-mail:gemingh@163.com基金资助:
国家自然科学基金（81602349）
Wang Jiafeng, Ge Minghua.
Online:2017-04-08Published:2017-05-09Contact:Ge Minghua E-mail:gemingh@163.comSupported by:
National Natural Science Foundation of China (81602349)
摘要：近十年，甲状腺癌发病率持续并快速增长，其发病风险因素成为社会关注的焦点。童年期电离辐射的暴露和遗传因素是甲状腺癌确定的风险因素；甲状腺肿、甲状腺良性结节或腺瘤和肥胖是甲状腺癌高度可能的风险因素；月经、生殖相关因素、饮食因素等是甲状腺癌可能的风险因素。
王佳峰,葛明华. 甲状腺癌发病风险相关因素分析[J]. 国际肿瘤学杂志, 2017, 44(4): 284-286.
Wang Jiafeng, Ge Minghua.. Analysis of risk factors of thyroid cancer[J]. Journal of International Oncology, 2017, 44(4): 284-286.
| ［1］ Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies［J］. Radiat Res, 2012, 178(2): AV43-AV60. DOI: 10.1667/RRAV05.1. ［2］ Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer［J］. Radiat Res, 2012, 178(4): 365-376. DOI: 10.1667/RR2889.1. ［3］ Williams D. Radiation carcinogenesis: lessons from chernobyl［J］. Oncogene, 2008, 27 Suppl 2: S9-S18. DOI: 10.1038/onc.2009.349. ［4］ Cardis E, Howe G, Ron E, et al. Cancer consequences of the chernobyl accident: 20 years on［J］. J Radiol Prot, 2006, 26(2): 127-140. DOI: 10.1088/09524746/26/2/001. ［5］ Memon A, Godward S, Williams D, et al. Dental x-rays and the risk of thyroid cancer: a case-control study［J］. Acta Oncol, 2010, 49(4): 447-453. DOI: 10.3109/02841861003705778. ［6］ Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence［J］. Epidemiology, 2009, 20(2): 181-187. DOI: 10.1097/EDE.0b013e318196ac1c. ［7］ Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American thyroid association［J］. Thyroid, 2009, 19(6): 565-612. DOI: 10.1089/thy.2008.0403. ［8］ Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer［J］. J Clin Endocrinol Metab, 2005, 90(10): 57475753. DOI: 10.1210/jc.2005-0935. ［9］ dos Santos Silva I. Swerdlow AJ. Sex differences in the risks of hormonedependent cancers［J］. Am J Epidemiol, 1993, 138(1): 10-28. ［10］ Negri E, Ron E, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer-Ⅰ. Methods［J］. Cancer Causes Control, 1999, 10(2): 131-142. DOI: 10.1023/A:1008851613024. ［11］ Dal Maso L, Bosetti C, La Vecchia C, et al. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors［J］. Cancer Causes Control, 2009, 20(1): 75-86. DOI: 10.1007/s10552-008-9219-5. ［12］ Franceschi S, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer［J］. Cancer Causes Control, 1999, 10(6): 583-595. ［13］ Singh B, Shaha AR, Trivedi H, et al. Coexistent hashimoto′s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome［J］. Surgery, 1999, 126(6): 1070-1076; discussion-1076-1077. ［14］ Kim KW, Park YJ, Kim EH, et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto′s thyroiditis［J］. Head Neck, 2011, 33(5): 691-695. DOI: 10.1002/hed.21518. ［15］ Anil C, Goksel S, Gursoy A. Hashimoto′s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid no-dules: a single-center prospective study［J］. Thyroid, 2010, 20(6): 601-606. DOI: 10.1089/thy.2009.0450. ［16］ Jankovic B, Le KT, Hershman JM. Clinical review: hashimoto′s thyroiditis and papillary thyroid carcinoma: is there a correlation?［J］. J Clin Endocrinol Metab, 2013, 98(2): 474-482. DOI: 10.1210/jc.2012-2978. ［17］ Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies［J］. Endocr Relat Cancer, 2009, 16(1): 17-44. DOI: 10.1677/ERC-08-0154. ［18］ Bosetti C, Kolonel L, Negri E, et al. A pooled analysis of case-control studies of thyroid cancer. Ⅵ. Fish and shellfish consumption［J］. Cancer Causes Control, 2001, 12(4): 375-382. ［19］ Bosetti C, Negri E, Kolonel L, et al. A pooled analysis of case-control studies of thyroid cancer. Ⅶ. Cruciferous and other vegetables (International) ［J］.Cancer Causes Control, 2002, 13(8): 765-775. ［20］ FeldtRasmussen U. Iodine and cancer［J］. Thyroid, 2001, 11(5): 483-486. DOI: 10.1089/105072501300176435. ［21］ Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood［J］. J Natl Cancer Inst, 2005, 97(10): 724-732. DOI: 10.1093/jnci/dji129. ［22］ Knobel M, Medeiros-Neto G. Relevance of Iodine intake as a reputed predisposing factor for thyroid cancer［J］. Arq Bras Endocrinol Metabol, 2007, 51(5): 701-712. ［23］ Xu L, Port M, Landi S, et al. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three casecontrol studies［J］. Thyroid, 2014, 24(6): 966-974. DOI: 10.1089/thy.2013.0566. ［24］ Bhaskaran K, Douglas I, Forbes HA, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults［J］. Lancet, 2014, 384(9945): 755-765. DOI: 10.1016/S0140-6736(14)60892-8. |
| [1] | 王子琪, 罗盼, 叶永英, 吴伟莉.甲状腺腺样囊性癌1例并文献复习[J]. 国际肿瘤学杂志, 2024, 51(3): 191-192. |
| [2] | 贺嘉慧, 胡钦勇.基于GBD数据的中国和美国肺癌发病和死亡趋势及危险因素对比分析[J]. 国际肿瘤学杂志, 2024, 51(1): 29-36. |
| [3] | 张劲男, 刘邦卿, 李军, 刘晓辉.BHLHE40靶向HMGA2激活氧化磷酸化通路降低甲状腺癌细胞对顺铂敏感性的研究[J]. 国际肿瘤学杂志, 2023, 50(7): 398-406. |
| [4] | 赵倩雯, 彭丹莉, 秦韬, 毛国飞, 唐辉, 杨峻.1990—2019年全球肿瘤发病死亡分析[J]. 国际肿瘤学杂志, 2023, 50(7): 425-431. |
| [5] | 李劲浩, 王桂东, 李雪菲, 刘子琳, 孟凯龙.静脉期CT值预测甲状腺乳头状癌中央组淋巴结转移的临床研究[J]. 国际肿瘤学杂志, 2022, 49(10): 581-585. |
| [6] | 段帅, 郭晨明, 李慧芳, 地力木拉提·艾斯木吐拉.1990—2019年中国女性乳腺癌发病死亡趋势及年龄-时期-队列模型分析[J]. 国际肿瘤学杂志, 2022, 49(10): 586-591. |
| [7] | 吴宇平, 张潇宇, 陆克义.PD-L1在甲状腺癌中的作用机制及其在诊疗中的应用[J]. 国际肿瘤学杂志, 2021, 48(9): 560-563. |
| [8] | 冯志平, 杨传周, 陈婷, 朱家伦, 刘超, 吕娟, 陆建梅, 邓智勇.BRD4抑制剂通过BRD4/miR-106b-5p/P21分子轴特异性抑制野生型Kras分化型甲状腺癌发展[J]. 国际肿瘤学杂志, 2021, 48(8): 463-472. |
| [9] | 侯小锋, 薛金才, 田尤新, 刘勤江.分化型甲状腺癌诊断与外科治疗四十年[J]. 国际肿瘤学杂志, 2020, 47(8): 449-456. |
| [10] | 程虎, 刘名奎, 陈天平.长非编码RNA AFAP1-AS1对甲状腺癌细胞增殖和侵袭的影响及其机制[J]. 国际肿瘤学杂志, 2020, 47(6): 327-332. |
| [11] | 王家乐, 曹君.甲状腺癌内科治疗进展[J]. 国际肿瘤学杂志, 2020, 47(4): 231-235. |
| [12] | 张李卓, 钱杨洋, 郑国湾, 葛明华.PD-1/PD-L1在肿瘤中的机制研究及其在甲状腺癌中的诊治价值[J]. 国际肿瘤学杂志, 2020, 47(1): 39-42. |
| [13] | 雷林，吉勇，尚庆刚，彭绩，任骅.深圳市2001—2015年白血病流行特征和时间趋势[J]. 国际肿瘤学杂志, 2019, 46(7): 415-419. |
| [14] | 武元元, 王军.甲状腺未分化癌的靶向药物治疗进展[J]. 国际肿瘤学杂志, 2019, 46(2): 98-101. |
| [15] | 董方, 薛金才, 王云生, 刘勤江.甲状腺癌外照射放射治疗的变迁[J]. 国际肿瘤学杂志, 2019, 46(11): 641-648. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||
